RxDoctor Payments Data

Adam Killpack, DO

Podiatrist · Port Angeles, WANPI 1720510829

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (45.0%), education and food and beverage — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Paragon 28, Inc. at 46.9% of the total. Reporting peaked in 2022 at $3,316 and has fallen 97.3% since, to $90 in 2025. Among podiatrist clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,462in general payments, 2019–2025

Across 28 payments — averaging $230.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$3K
  • Summit Surgical Corp.$2K
  • Arthrex$2K
  • Orthofix Medical, Inc.$138
  • Mimedx Group, Inc.$99
  • Johnson & Johnson$16

What the payments were for

  • Travel & lodging$2,90845%
  • Food & beverage$1,15418%
  • Education$2,40037%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,462 in reported general payments places this provider in the 90th percentile of 134 podiatrist providers in Washington.

See all podiatrist providers in Washington

Medicare billing

Part B allowed, 2024
$89,115
Medicare patients
469
Services billed
1,487

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam11$83
Doxycycline Hyclate14$82
Cefadroxil14$74
Oxycodone Hcl18$64

Paid to pharmacies, not to this prescriber.

Other podiatrist in Port Angeles

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →